Vivos Inc (RDGL)

[DaddyNewb]

So, let’s speculate, just for a bit, on a buy out price and what this could really be worth. If I just look at the treating of animals, it’s roughly 12 million cats and dogs a year that are stricken with cancer of some form. For arguments sake, let’s say that 10% of those have a cancer that IsoPet can treat, as of now. At 5k a treatment, that’s 6 billion a year.

For IsoPet alone, wouldn’t 6 Billion be a respectable purchase? About $6.01 a share?

Now if human trials start before a buyout and are successful. I would say just double the above. Or do you think higher?

I’m bringing this up because I just read of AbbVie that spent 10 Billion on a cancer drug that didn’t even have FDA approval at the time purchase and here we have something that is obviously working and should really only be a matter of time before it’s picked up.